Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCB Insights

The AI agent market map

View original at cbinsights.com
CB Insights - Enterprise Ai Title: The AI agent market map Date: 2025-11-10 20:14 Source: https://www.cbinsights.com/research/ai-agent-market-map-2025/ <p>The AI agent moment is reshaping enterprise software.</p> <p>Since <a href="https://www.cbinsights.com/research/ai-agent-market-map/">our last mapping in March 2025<…
Opening lines of the source · CB Insights · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Horizontal AI agent startups outnumber verticalized solutions nearly 2-to-1 in the landscape.

    80% confidence
  • Agentic solutions have become a leading acquisition target for enterprise software incumbents.

    80% confidence
  • AI agent startups focused on cybersecurity operations are most primed to exit based on average CB Insights M&A probability scores.

    80% confidence
  • The private AI agent market is moving towards greater specialization, with industry-specific solutions surging since March 2025.

    80% confidence
  • Since March 2025, the AI agent landscape has exploded from roughly 300 players to thousands as tech companies race to launch AI agent offerings.

    80% confidence
  • AI-related cybersecurity M&A has already reached record levels in 2025.

    80% confidence
  • The healthcare and life sciences AI agent category grew from 7 companies in March 2025 to 47 companies in the November 2025 map iteration.

    80% confidence
  • Emerging startups are betting that highly regulated industries will favor specialized AI agent solutions over horizontal tools.

    80% confidence
  • 1 in 5 new unicorns ($1B+ valuation) are now developing AI agents.

    80% confidence
  • AI agents combine reasoning, memory, tool use, and planning capabilities.

    80% confidence
  • The software development AI agent market is the most crowded on the map, reflecting the value agents bring to well-defined workflows and testable environments.

    80% confidence
  • The coding AI agent market is facing challenges as reasoning models drive higher inference costs, previewing pricing pressures other agent categories will face.

    80% confidence
  • The top 20 AI agent revenue leaders average just 3.8 years old, with software development leading revenue activity featuring 6 coding agents.

    80% confidence
  • Nullify and Strike Ready top the cybersecurity acquisition probability list with 70%+ probability of getting acquired within the next two years.

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,351 source documents archived
Query this data → isubstrate.com